-
1
Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer
Published 2020-09-01Subjects: Get full text
Article -
2
Nomogram-derived prediction of pathologic complete response (pCR) in breast cancer patients treated with neoadjuvant chemotherapy (NCT)
Published 2020-11-01Subjects: Get full text
Article -
3
Biomarkers of Favorable vs. Unfavorable Responses in Locally Advanced Rectal Cancer Patients Receiving Neoadjuvant Concurrent Chemoradiotherapy
Published 2022-05-01Subjects: Get full text
Article -
4
-
5
-
6
Impact of vitamin D on pathological complete response and survival following neoadjuvant chemotherapy for breast cancer: a retrospective study
Published 2018-07-01Subjects: Get full text
Article -
7
Platinum-based neoadjuvant chemotherapy in BRCA1-positive breast cancer: a retrospective cohort analysis and literature review
Published 2018-04-01Subjects: Get full text
Article -
8
Patients achieved pCR during neoadjuvant chemotherapy had better outcome than adjuvant chemotherapy setting in breast cancer: A comparative study
Published 2023-01-01Subjects: Get full text
Article -
9
-
10
Construction of a risk stratification model integrating ctDNA to predict response and survival in neoadjuvant-treated breast cancer
Published 2023-12-01Subjects: Get full text
Article -
11
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study
Published 2024-08-01Subjects: Get full text
Article -
12
Factors influencing pathological complete response and tumor regression in neoadjuvant radiotherapy and chemotherapy for high-risk breast cancer
Published 2024-07-01Subjects: Get full text
Article -
13
-
14
Comprehensive evaluation of the relationship between biomarker profiles and neoadjuvant chemotherapy outcomes for breast cancer patients
Published 2024-03-01Subjects: Get full text
Article -
15
Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy
Published 2024-08-01Subjects: Get full text
Article -
16
Individualized model for predicting pathological complete response to neoadjuvant chemotherapy in patients with breast cancer: A multicenter study
Published 2022-08-01Subjects: Get full text
Article -
17
Prediction of pathological complete response after neoadjuvant chemotherapy for HER2-negative breast cancer patients with routine immunohistochemical markers
Published 2025-01-01Subjects: “…pCR…”
Get full text
Article -
18
-
19
Neoadjuvant chemotherapy with or without anthracyclines in combination with single HER2-targeted therapy in HER2-positive breast cancer
Published 2023-01-01Subjects: Get full text
Article -
20
Neoadjuvant therapy for HER2-positive breast cancer
Published 2019-06-01Subjects: Get full text
Article